Published on
Jan 18, 2025
University of Chicago Thought Process on First-line Treatment in EGFR NSCLC
A panel of clinicians located at the University of Chicago convened to discuss the first-line use of first-line treatment options for patients with EGFR-mutated non–small cell lung cancer. The discussion focused on the phase 3 MARIPOSA study (NCT04487080), …
Source:
Cancer Network - New Jersey
-
Label Pending
